FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> GAVI Alliance

Vaccines critical for controlling chronic diseases

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!



Tools

Vaccines are a vital part of controlling non-communicable diseases (NCDs) around the world, even though most shots are designed to prevent illnesses that can be passed from person-to-person. That's according to health experts who spoke at a recent U.N. General Assembly summit on NCDs.

"A number of what we call NCDs turn out to be infectious diseases. About 20% of cancer is actually caused by infectious agents.  We've had a lot of success getting rid of hepatitis B, which is the largest cause of liver cancer and we are hoping with the...[HPV vaccine] to be able to get rid of cervical cancer," noted GAVI Alliance CEO Seth Berkley. Increased vaccine access worldwide is one way to prevent many NCDs, but other risk factors--like obesity, heart conditions, diabetes and many cancers--will have to be dealt with in other ways.

- read the article for more

PLUS: Every year more than 2 million kids die before the age of 5 due to vaccine-preventable diseases. In an effort to further protect children from preventable diseases (and, in the long run, NCDs) the GAVI Alliance announced this week it would commit $3.4 billion over the next four years for rotavirus and pneumonia vaccines for children in 37 developing countries. Of the countries targeted by the funding, two dozen are in Africa. News


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about GAVI Alliance